ING Groep NV Invests $2.29 Million in Mettler-Toledo International, Inc. $MTD

ING Groep NV acquired a new position in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,640 shares of the medical instruments supplier’s stock, valued at approximately $2,286,000.

Several other institutional investors have also recently made changes to their positions in the business. EverSource Wealth Advisors LLC lifted its stake in shares of Mettler-Toledo International by 2.4% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier’s stock worth $361,000 after purchasing an additional 7 shares during the period. Allworth Financial LP increased its holdings in Mettler-Toledo International by 6.1% in the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier’s stock worth $149,000 after acquiring an additional 7 shares in the last quarter. Evergreen Capital Management LLC increased its holdings in Mettler-Toledo International by 4.5% in the 4th quarter. Evergreen Capital Management LLC now owns 184 shares of the medical instruments supplier’s stock worth $257,000 after acquiring an additional 8 shares in the last quarter. Meridian Wealth Management LLC increased its holdings in Mettler-Toledo International by 1.7% in the 4th quarter. Meridian Wealth Management LLC now owns 488 shares of the medical instruments supplier’s stock worth $680,000 after acquiring an additional 8 shares in the last quarter. Finally, Verdence Capital Advisors LLC increased its holdings in Mettler-Toledo International by 2.0% in the 4th quarter. Verdence Capital Advisors LLC now owns 458 shares of the medical instruments supplier’s stock worth $639,000 after acquiring an additional 9 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,161.76 on Wednesday. Mettler-Toledo International, Inc. has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The company has a 50 day simple moving average of $1,211.50 and a two-hundred day simple moving average of $1,319.07. The firm has a market cap of $23.48 billion, a P/E ratio of 27.25, a price-to-earnings-growth ratio of 2.37 and a beta of 1.27.

Mettler-Toledo International (NYSE:MTDGet Free Report) last announced its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. During the same period last year, the firm posted $8.19 EPS. The company’s revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 46.6 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on MTD shares. Citigroup reduced their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a report on Friday, May 8th. Jefferies Financial Group raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating and increased their target price for the stock from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Barclays reduced their target price on shares of Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Wolfe Research started coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Finally, Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and a consensus target price of $1,408.55.

View Our Latest Stock Report on Mettler-Toledo International

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Read More

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.